FABP4 and rheumatoid arthritis: The inhibition of mTORC1 with rapamycin, an mTOR pathway inhibitor, via the ras homolog enriched in brain (Rheb1) in the myeloid lineage reduced the M1 macrophage expression of FABP4, resulting in an attenuation of RA development [2].